Advertisement

Role of fibrin deposition in the pathogenesis of intraabdominal infection

  • O. D. Rotstein
Current Topic: Review

Abstract

The production of fibrinous exudates plays an important role in determining the outcome of peritoneal infection. Large numbers of bacteria are sequestered within fibrin matrices, thereby retarding bacterial spread throughout the peritoneal cavity and into the bloodstream. This walling-off process is teleologically advantageous in that it lessens early rapid mortality. Recent studies have documented that this same process is probably integral to the development of residual infection in the peritoneum. Bacteria sequestered within fibrin deposits are protected from normal host clearance mechanisms, thereby permitting unopposed proliferation and ultimately the establishment of an abscess. A complete understanding of the cellular and noncellular aspects of the host response to peritoneal infection will suggest novel strategies both to treat and to prevent the development of intraabdominal abscesses and their attendant consequences.

Keywords

Internal Medicine Peritoneal Cavity Host Response Complete Understanding Attendant Consequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hau T, Simmons RL Secondary bacterial peritonitis. The biologic basis of treatment. Current Problems in Surgery 1979, 16: 1–65.Google Scholar
  2. 2.
    Steinberg B Infections of the peritoneum. Hoeber, New York, 1944.Google Scholar
  3. 3.
    Dunn DL, Barke RA, Ewald DC, Simmons RL Macrophages and translymphatic absorption represent the first line of host defense in the peritoneal cavity. Archives of Surgery 1987, 122: 105–110.PubMedGoogle Scholar
  4. 4.
    Rotstein OD Peritonitis and intraabdominal abscesses. In: Wilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL (eds): Care of the surgical patient. Scientific American, New York, 1992, p. 8:1–8:24.Google Scholar
  5. 5.
    Almdahl SM, Osterud B, Melby K, Giercksky KE Mononuclear phagocyte thromboplastin, bacterial counts and endotoxin levels in experimental endogenous gram-negative sepsis. Acta Chirurgia Scandanavica 1986, 153: 351–355.Google Scholar
  6. 6.
    Zinsser HH, Pryde AW Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Surgery 1952, 130: 818–827.Google Scholar
  7. 7.
    Dunn DL, Simmons RL Fibrin in peritonitis. III. The mechanism of bacterial trapping by polymerizing fibrin. Surgery 1982, 92: 513–519.PubMedGoogle Scholar
  8. 8.
    Rotstein OD, Pruett TL, Simmons RL Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing ofEscherichia coli by human polymorphonuclear leukocytes. Annals of Surgery 1986, 203: 413–419.PubMedGoogle Scholar
  9. 9.
    Whitnack E, Beachey EH Inhibition of complement-mediated opsonization and phagocytosis ofStreptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. Journal of Experimental Medicine 1985, 162: 1983–1997.CrossRefPubMedGoogle Scholar
  10. 10.
    Kazura JW, Wenger JD, Salata RA, Budzynski AZ, Goldsmith GH Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E. Journal of Clinical Investigation 1989, 83: 1916–1924.PubMedGoogle Scholar
  11. 11.
    Ahrenholz DH, Simmons RL Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. Coli peritonitis. Surgery 1980, 88: 41–47.PubMedGoogle Scholar
  12. 12.
    Fry DE, Garrison RN, Heitsch RC, Calhoun K, Polk Jr HC Determinants of death in patients with intraabdominal abscess. Surgery 1980, 88: 517–523.PubMedGoogle Scholar
  13. 13.
    Rotstein OD, Kao J Fibrinolysis using recombinant tissue plasminogen activator prevents intraabdominal abscesses. Journal of Infectious Diseases 1988, 158: 766–772.PubMedGoogle Scholar
  14. 14.
    Houston K, McRitchie DI, Rotstein OD Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing. Annals of Surgery 1990, 211: 130–135.PubMedGoogle Scholar
  15. 15.
    McRitchie DI, Cummings D, Rotstein OD Delayed administration of tissue plasminogen activator reduces intraabdominal abscess formation. Archives of Surgery 1989, 124: 1406–1410.PubMedGoogle Scholar
  16. 16.
    Rodeheaver G, Marsh D, Edgerton MT, Edlich RF Proteolytic enzymes as adjuncts to antimicrobial prophylaxis of contaminated wounds. American Journal of Surgery 1975, 129: 537–544.CrossRefPubMedGoogle Scholar
  17. 17.
    Nankivell BJ, Lake N, Gillies A Intracatheter streptokinase for recurrent peritonitis in CAPD. Clinical Nephrology 1991, 35: 20–23.PubMedGoogle Scholar
  18. 18.
    Polk BF, Kasper DL Bacteroides fragilis subspecies in clinical isolates. Annals of Internal Medicine 1977, 86: 569–571.PubMedGoogle Scholar
  19. 19.
    Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG The capsular polysaccharide ofB. fragilis as a virulence factor: comparison of pathogenic potential of encapsulated and unencapsulated strains. Journal of Infectious Diseases 1977, 136: 82–89.PubMedGoogle Scholar
  20. 20.
    Rosenthal GA, Levy G, Rotstein OD Induction of macrophage procoagulant activity byBacteroides fragilis. Infection and Immunity 1989, 57: 745–753.PubMedGoogle Scholar
  21. 21.
    Maier RV, Hahnel GB, Pohlman TH Endotoxin requirements for alveolar macrophage stimulation. Journal of Trauma 1990, 30: 549–557.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992

Authors and Affiliations

  • O. D. Rotstein
    • 1
  1. 1.Department of SurgeryToronto General HospitalTorontoCanada

Personalised recommendations